Condensed Consolidated Statements of Operations (USD $)	3 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Income Statement [Abstract]
Sales, net		$ 313,993
Cost of sales		151,661
Gross margin		162,332
Operating Expenses:
Sales and marketing	359,600	553,185
Impairment of Goodwill	21,633,882
General and administrative expense	2,927,430	1,226,153
Total expenses	24,920,912	1,779,338
Loss from operations	(24,920,912)	(1,617,006)
Other income (expense):
Other income	1,282
Interest expense	(95,061)	(393,541)
Loss on sale of marketable securities	(211)
Dividend on Series A preferred shares	(231,631)
Expense on issuance of warrant derivative liabilities		(170,616)
Change in fair value of derivative liabilities	723,712	(2,630,024)
Other income, total	398,091	(3,194,181)
Net loss	(24,522,821)	(4,811,187)
Net loss attributable to the non-controlling interest	(96,900)
Net loss attributable to Fuse Science, Inc. Common Shareholders	$ (24,425,921)	$ (4,811,187)
Net loss per share attributable to Fuse Science, Inc. common shareholders, basic and diluted	$ (0.66)	$ (0.15)
Weighted average shares outstanding, basic and diluted	37,169,212	32,848,676